Infections as a major preventable cause of human cancer

Journal of Internal Medicine - Tập 248 Số 3 - Trang 171-183 - 2000
Hannah Kuper1, Hans‐Olov Adami2,1, D. Trichopoulos3,2,1
1From the Department of Epidemiology, Harvard School of Public Health Boston, MA., USA
2Department of Medical Epidemiology, Karolinska Institute, Stockholm, Sweden
3Department of Hygiene and Epidemiology, University of Athens Medical School, Athens, Greece

Tóm tắt

Abstract. Kuper H, Adami H‐O & Trichopoulos D (Harvard School of Public Health, Boston, MA, USA; Karolinska Institute, Stockholm, Sweden; University of Athens Medical School, Greece). Infections as a major preventable cause of human cancer (Internal Medicine in the 21st Century). J Intern Med 2000; 248: 171–183.

Infections may be responsible for over 15% of all malignancies worldwide. Important mechanisms by which infectious agents may induce carcinogenesis include the production of chronic inflammation, the transformation of cells by insertion of oncogenes and inhibition of tumour suppressors, and the induction of immunosuppression. Common characteristics shared by infectious agents linked to malignancies are that they are persistent in the host, often highly prevalent in the host population and induce cancer after a long latency. The associations between a selection of infectious agents and malignancies are covered in detail.

Từ khóa


Tài liệu tham khảo

Parsonnet J., 1999, Microbes and Malignancy., 3

10.1093/carcin/21.3.405

PisaniP ParkinDM MunozN FerlayJ.Cancer and infection: estimates of the attributable fraction in 1990.Cancel Epidemiol Biomarkers Prev1997;6:387400(Review).

10.1016/0027-5107(94)90245-3

Cohen SM, 1991, Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis., Mod Pathol, 4, 371

10.1093/oxfordjournals.jncimonographs.a024164

Zur Hausen H., 1999, Microbes and Malignancy., 107

10.1177/003591576505800503

Kane M., 1995, Global programme for control of hepatitis B infection., Vaccine, 13, S47, 10.1016/0264-410X(95)93547-M

10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I

Wild CP, 1999, Infections and Human Cancer., 35

10.1098/rspb.1993.0102

IARC, Hepatitis viruses., 1994, IARC monographs on the evaluation of carcinogenic risks to humans.

10.1023/A:1008951901148

10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2

Kaklamani E, 1991, Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma., JAMA, 265, 1974, 10.1001/jama.1991.03460150078027

10.1016/0140-6736(92)91528-G

Robinson WS., 1999, Microbes and Malignancy., 232

10.1073/pnas.88.20.9248

Wang WL, 1991, Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer., Cancer Res, 51, 4971

10.1016/0006-291X(91)90379-L

10.1002/(SICI)1097-0215(19960917)67:6<892::AID-IJC21>3.0.CO;2-2

Becker SA, 1998, Hepatitis B virus X protein interferes with cellular DNA repair., J Virol, 72, 266, 10.1128/JVI.72.1.266-272.1998

10.1016/S0065-230X(08)60306-1

10.1002/ijc.2910390109

10.7326/0003-4819-116-2-97

10.1002/1097-0142(19820315)49:6<1206::AID-CNCR2820490623>3.0.CO;2-7

Pawlotsky JM., 1998, Genetic heterogeneity and properties of hepatitis C virus., Acta Gastroenterol Belg, 61, 189

10.1016/S0966-842X(99)01590-5

10.1056/NEJM199908193410802

10.1046/j.1365-2893.1999.6120139.x

10.1046/j.1525-1381.1999.t01-1-99240.x

Chung RT, 1999, Microbes and Malignancy., 267

10.1002/hep.1840220403

Saito K, 1997, Detection of hepatitis C virus RNA sequences in hepatocellular carcinoma and its precursors by microdissection polymerase chain reaction., Arch Pathol Lab Med, 121, 400

10.1016/S0140-6736(95)90400-X

10.1016/0168-1702(95)00034-N

Ray RB, 1996, Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype., J Virol, 70, 4438, 10.1128/jvi.70.7.4438-4443.1996

10.1006/viro.1996.0644

Matsumoto M, 1997, Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin‐beta receptor., J Virol, 71, 1301, 10.1128/jvi.71.2.1301-1309.1997

Zhang Q, 1994, Functional and physical interaction between p53 and BZLF1: implications for Epstein–Barr virus latency., Mol Cell Biol, 14, 1929

Zacny VL, 1998, The Epstein–Barr virus immediate–early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle., J Virol, 72, 8043, 10.1128/JVI.72.10.8043-8051.1998

IARC, Infections with Epstein–Barr virus, human herpes viruses., 1997, IARC monographs on the evaluation of carcinogenic risks to humans., 70

10.1016/S0065-230X(08)60470-4

Pagona JS., 1975, Cold Spring Harbor Symposium on quantitative biology: tumor viruses, XXIX, 797

10.1016/1047-2797(90)90020-S

10.1002/ijc.2910350404

10.1038/sj.onc.1202468

10.1007/BF00053132

10.1002/ijc.2910260203

Gutensohn N, 1980, Epidemiology of Hodgkin’s disease., Semin Oncol, 7, 92

MacMahon B., 1966, Epidemiology of Hodgkin’s disease., Cancer Res, 26, 1189

10.1056/NEJM198903163201103

10.1002/ijc.2910340203

IARC., 1995, Monographs on the Evaluation of Carcinogenic Risks to Humans no. 64.

10.1093/jnci/92.9.690

10.1006/bbrc.1996.0707

10.1128/JVI.74.6.2679-2686.2000

10.1126/science.2157286

Scheffner M, 1992, Interaction of the human papillomavirus type 16, E6 oncoprotein with wild–type and mutant human p53 proteins., J Virol, 66, 5100, 10.1128/jvi.66.8.5100-5105.1992

Lechner MS, 1994, Inhibition of p53 DNA binding by human papillomavirus E6 proteins., J Virol, 68, 4262, 10.1128/jvi.68.7.4262-4273.1994

10.1002/j.1460-2075.1991.tb04990.x

10.1099/0022-1317-80-7-1707

Thomas JT, 1998, Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint., J Virol, 72, 1131, 10.1128/JVI.72.2.1131-1137.1998

10.1038/380079a0

Morozov A, 1997, Accumulation of human papillomavirus type 16, E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21., J Virol, 71, 3451, 10.1128/jvi.71.5.3451-3457.1997

10.1002/j.1460-2075.1989.tb08594.x

Jewers RJ, 1992, Regions of human papillomavirus type 16, E7 oncoprotein required for immortalization of human keratinocytes., J Virol, 66, 1329, 10.1128/jvi.66.3.1329-1335.1992

10.1002/j.1460-2075.1996.tb00546.x

10.1101/gad.11.16.2101

10.1056/NEJM199804023381403

10.1038/nm0896-925

Chang Y., 1999, Microbes and Malignancy., 207

10.1016/0140-6736(90)90001-L

10.1056/NEJM199505043321801

10.1086/515649

10.1016/S1359-6101(97)00037-3

10.1007/BF00052359

10.1093/infdis/167.1.57

10.1007/978-1-4899-0036-4_24

Hisada M, 1998, Risk factors for adult T‐cell leukemia among carriers of human T‐lymphotropic virus type I., Blood, 92, 3557, 10.1182/blood.V92.10.3557.422k09_3557_3561

Uchiyama T, 1977, Adult T‐cell leukemia: clinical and hematologic features of 16 cases., Blood, 50, 481, 10.1182/blood.V50.3.481.481

10.1093/infdis/147.3.406

10.1007/978-3-642-70113-9_11

10.1038/294770a0

IARC. Human immunodeficiency viruses and human T‐cell lymphotropic viruses., 1996, Monographs on the Evaluation of Carcinogenic Risks to Humans no. 67.

Newton R, 1999, Infections and Human Cancer., 237

10.1016/0140-6736(93)90938-D

Holcombe C, 1992, H. pylori, the most common bacterial infection in Africa: a random serological study., Am J Gastroenterol, 8, 28

10.1016/S0016-5085(97)80004-2

IARC. Schistosomes, Liver Flukes and Helicobacter Pylori., 1994, Monographs on the Evaluation of Carcinogenic Risks to Humans no. 61.

Danesh J., 1999, Infections and Human Cancer., 263

10.1002/ijc.2910470405

10.1056/NEJM199405053301803

EkströmA‐M.Factors related to the occurence of gastrric adenocarcinoma subtypes.Doctoral Dissertation Stockholm: Karolinska Institutet 2000.

Blaser MJ, 1995, Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk., Cancer Res, 55, 562

10.1093/oxfordjournals.bmb.a011662

Correa ME, 1998, Ultrastructure of hepatocyte abnormalities in perimetastatic areas., J Submicrosc Cytol Pathol, 30, 371

World Health Organisation., 1993, The Control of Schistosomiasis: Second Report of the WHO Expert Committee.

10.1016/0027-5107(94)90248-8

10.1177/030006059302100601

10.1002/ijc.2910480302

Sriurairatana S, 1996, Ultrastructural characteristics of liver fluke associated human cholangiocarcinoma cell lines., Southeast Asian J Trop Med Public Health, 27, 57

10.1016/0027-5107(94)90244-5

10.1093/carcin/14.11.2415